Tony Duong

Oct 30, 2024 | advancingrna.com | AR Welch |Advancing RNA |Ben Comer |Tony Duong

It’s impossible to attend an event on the future of RNA therapeutics without hearing about the challenges we’re facing with targeted RNA-LNP delivery. In this final Advancing RNA Live discussion of 2024, we sit down with three LNP experts to parse out the current opportunities and unknowns facing the development of next-generation LNPs. Secure your spot today! Registration is free thanks to the support of Helix Biotech.

Mar 1, 2024 | drugdeliveryleader.com | Tony Duong

By Tony Duong, Ph.D., Nanoscientist, Lead Drug Delivery Scientist Gene therapies and nanomedicines have the potential to revolutionize medicine, but their success depends on navigating regulatory pathways effectively. Collaboration, transparency, and patient safety are crucial in accelerating the development and use of these therapies. Gene therapies combined with nanocarrier technology provide precise delivery vehicles for targeted treatments.